Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase NA 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 16Carcinoma, Non-Small-Cell Lung 7Rectal Neoplasms 6Colorectal Neoplasms 6Pancreatic Neoplasms 5Lung Neoplasms 5Colonic Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Renal Cell 4Urinary Bladder Neoplasms 3Prostatic Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Melanoma 3Lymphoma, Follicular 3Head and Neck Neoplasms 3Carcinoma, Ovarian Epithelial 3Breast Neoplasms, Male 3Sezary Syndrome 2Mycosis Fungoides 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Liver Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Neoplasms 2Immunoblastic Lymphadenopathy 2

Interventions

Cyclophosphamide 17Trastuzumab 16Paclitaxel 15Doxorubicin 11Docetaxel 10Radiotherapy 9Carboplatin 9Capecitabine 9Bevacizumab 8Lapatinib 7Taxes 6Tamoxifen 6Gemcitabine 5Filgrastim 5Chemotherapy, Adjuvant 5sargramostim 4Sorafenib 4Radiation 4Neoadjuvant Therapy 4Granulocyte-Macrophage Colony-Stimulating Factor 4Vinorelbine 3Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Irinotecan 3Immunohistochemistry 3Granulocyte Colony-Stimulating Factor 3Erlotinib Hydrochloride 3Anastrozole 3Albumin-Bound Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms, Male × Immunohistochemistry × Clear all
NCT00482755 2024-02-12

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Canadian Cancer Trials Group

Phase 2 Completed
4 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00468715 2022-08-03

Bicalutamide in Treating Patients With Metastatic Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
28 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00847171 2018-09-26

Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
20 enrolled 6 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡